Drug Shortage Report for LACTATED RINGER'S INJECTION, USP
Report ID | 158687 |
Drug Identification Number | 00061085 |
Brand name | LACTATED RINGER'S INJECTION, USP |
Common or Proper name | Lactated Ringer's Injection USP |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CALCIUM CHLORIDE POTASSIUM CHLORIDE SODIUM LACTATE SODIUM CHLORIDE |
Strength(s) | 20MG 30MG 310MG 600MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1000ML |
ATC code | B05BB |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-04-14 |
Actual start date | 2022-04-14 |
Estimated end date | 2022-04-22 |
Actual end date | 2022-04-20 |
Shortage status | Resolved |
Updated date | 2022-04-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-04-21 | English | Compare |
v5 | 2022-04-20 | French | Compare |
v4 | 2022-04-20 | English | Compare |
v3 | 2022-04-15 | English | Compare |
v2 | 2022-04-12 | French | Compare |
v1 | 2022-04-12 | English | Compare |
Showing 1 to 6 of 6